Cardiac magnetic resonance (CMR) is a valuable tool for the evaluation of patients with, or
at risk for, heart failure and has a growing impact on diagnosis, clinical management, and …

Cardiac magnetic resonance (CMR) imaging is widely used in various medical fields related
to cardiovascular diseases. Rapid technological innovations in magnetic resonance imaging …

Purpose To determine whether quantitative tissue characterization with T1 and T2 mapping
supports recognition of myocardial involvement in patients with systemic sarcoidosis …

Quantitative myocardial and blood T 1 have recently achieved clinical utility in numerous
pathologies, as they provide non-invasive tissue characterization with the potential to …

Background Myocardial T 1-mapping recently emerged as a promising quantitative method
for non-invasive tissue characterization in numerous cardiomyopathies. Commonly …

Objectives To evaluate the ability of late gadolinium enhancement (LGE) and mapping
cardiac magnetic resonance (CMR) including native T1 and global extracellular volume …

Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy with a
prevalence of 1 in 500 in the general population. Since the first pathological case series at …

Cardiac magnetic resonance (MR) imaging with late gadolinium enhancement (LGE) is
used to detect and assess the myocardial damage seen with a variety of cardiomyopathies …

Objectives We aimed to evaluate the prognostic role of cardiac magnetic resonance imaging
(CMR)–based extracellular volume fraction (ECV) in patients with non-ischemic dilated …

Congenital heart disease (CHD) is the most common category of birth defect, affecting 1% of
the population and requiring cardiovascular surgery in the first months of life in many …